Biopharmaceutical company interrogating stem cell biology
Advocated for funding to advance from basic research to clinical readiness a first generation stem cell medicine to restore hearing, by using the fundemental biological mechanisms that guide cell fate to develop innovative therapeutics.  Fate's research and drug development focuses on modulating adult stem cell biology to treat disease and improve health. Advocated for funding to advance from basic research to clinical readiness a first generation stem cell medicine to restore hearing by using the fundemental biological mechanisms that guide cell fate to develop innovative therapeutics.  Fate's research and drug development focuses on modulating adult stem cell biology to treat disease and improve health. Advocated for funding to advance from basic research to clinical readiness a first generation stem cell medicine to restore hearing,  by using the fundemental biological mechanisms that guide cell fate to develop innovative therapeutics.  Fate's research and drug development focuses on modulating adult stem cell biology to treat disease and improve health.
BUD - Budget/Appropriations MED - Medical/Disease Research/Clinical Labs DEF - Defense
116 - Defense Advanced Research Projects Agency (DARPA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 116 - Defense Advanced Research Projects Agency (DARPA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 116 - Defense Advanced Research Projects Agency (DARPA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE PETRIZZO GROUP, INC.
601 New Jersey Ave NW, Suite 830, Washington, DC, 20001, US
TJ PETRIZZO TJ PETRIZZO TJ PETRIZZO